July 1, 2024

Inhibition of FoxO1 ameliorates hepatic steatosis and hepatitis in nonalcoholic steatohepatitis mice through regulation of gut microbiota

Key Points

Key points are not available for this paper at this time.

Abstract

We aimed to investigate the role of forkhead box O1 (FoxO1) inhibitor AS1842856 (AS) in nonalcoholic steatohepatitis (NASH) mice and the potential mechanisms.

Bookmark

Cite This Study

Shou et al. (Mon,) studied this question.

synapsesocial.com/papers/68e624b1b6db6435875b744d https://doi.org/https://doi.org/10.1111/1751-2980.13306

Bookmark